Posterior circulation cerebral aneurysms are at higher risk of rupture and are more symptomatic than those in the anterior circulation. Existing treatments carry significant morbidity. Early reports of flow diversion for posterior circulation aneurysms have suggested high complication and low occlusion rates. OBJECTIVE: To report safety and efficacy of flow diversion with the pipeline embolization device (ev3, Medtronic Inc, Dublin, Ireland) for aneurysms located throughout the posterior circulation. METHODS: A prospective, institutional review board-approved database was analyzed for all patients with posterior circulation aneurysms treated by flow diversion at our institution. RESULTS: Fifty-nine embolization procedures were performed on 55 patients. Average aneurysm size was 9.4 mm. Morphology was saccular (45%), fusiform (29%), or dissecting/pseudo-aneurysms (25%). Sixty-two percent of aneurysms arose along the vertebral artery. There were 7 mid-basilar (13%) and 7 basilar apex (13%) aneurysms. Procedural success was 98%; 1 Pipeline embolization device was placed in 85%; and coiling was performed in 17% of cases. There were 5 major complications (8%), all strokes. Patients with major stroke had modified Rankin Scale score at last follow-up of 1, 3, 4, 6, and 6 (2 mortalities). There were zero intracerebral or subarachnoid hemorrhages. No variable predicted complications on univariate or multivariate analysis. Follow-up digital subtraction angiography was performed for 43 patients (78%). Complete occlusion was 68% at 6 mo and 78% at 12 mo. Average follow-up was 11.8 mo. Fusiform or dissecting morphology and large or giant aneurysm size were predictors of aneurysm persistence at 6 mo on multivariate logistic regression. CONCLUSION: This is a large single-institution series of Pipeline (Medtronic Inc) for posterior circulation aneurysms and demonstrates acceptable safety and effectiveness in these challenging cases.
anterior circulation aneurysms, there is a higher proportion of nonsaccular morphologies, which commonly present with ischemic or compressive symptoms.
1 Saccular aneurysms of the posterior circulation are at higher risk of rupture than their anterior circulation counterparts 2 and, when ruptured, present in worse clinical grade. 3 This creates an impetus toward elective treatment, but existing treatments are limited by morbidity and efficacy. Surgery for these lesions-because of the deep exposure and proximity of cranial nerves and perforating arteries-carries high morbidity. 4, 5 Endovascular coiling has lower morbidity but comparatively inferior occlusion outcomes. 6 Residual and recanalizing posterior circulation aneurysms remain at significant rupture risk 7 and retreatment of these lesions is technically challenging. Originally approved for large internal carotid artery aneurysms, flow diverting stents have been trialed for posterior circulation aneurysms. Published series are small and report mixed results. Here, we present a large, single-center case series of patients with aneurysms throughout the posterior circulation that were treated by flow diversion using the Pipeline embolization device (PED; ev3, Medtronic Inc, Dublin, Ireland).
METHODS
The study was a retrospective cohort of patients utilizing an institutional review board-approved, prospectively collected database of aneurysm patients at a tertiary medical center. Patients were identified who underwent flow diversion of a posterior circulation aneurysm with the PED between August 2011 and August 2017. Individual patient consent was not required or sought, as data are collected in a deidentified manner on routine clinical practice at our institution and poses no risk to patients. The decision to treat was based on demographics, symptoms, location, and morphology among other factors without strict criteria for size or growth on serial imaging. The pipeline procedure was performed in the manner previously described. 8, 9 Patients were started on dual antiplatelet therapy (DAT) with Aspirin 325 mg daily and Clopidogrel 75 mg daily 1 wk before their scheduled procedure. Patients recovered in the neurocritical care unit and were typically discharged home on postembolization day 1. Demographics, clinical history, and patient outcomes were collected from medical records. Anatomic and procedural details were collected from angiograms and operative reports. Major stroke was defined as a change in the National Institutes of Health (NIH) stroke scale >4 lasting more than 7 d; minor stroke was a change in the NIH stroke scale ≤4 lasting less than 7 d with corroborative imaging, and transient ischemic attack (TIA) was a transient neurological deficit without corroborative imaging. Follow-up consisted of catheter cerebral angiography at 6 and 12 mo postembolization. Occlusion was graded according to the O'Kelly-Marotta scale as complete, trace filling, entry remnant, or aneurysm filling. 10 Multivariate logistic regression was performed to identify predictors of complication and aneurysm persistence.
Statistical Analysis
Data are presented as means and range for continuous variables and as frequency for categorical variables. Univariate logistic regression was used to test predictors of any complication and aneurysm persistence at 6 mo. Both outcome variables were selected to maximize the number of observations and covariates that could be tested. Covariates included age, gender, race, symptomatic aneurysms, prior treatments, aneurysm size, vessel of origin, morphology, and device number. The strongest models, assessed by pseudo-R 2 , incorporated all covariates into the multivariate logistic regression. A threshold of P < .05 was used to determine significance. Statistical analysis was performed using Stata (version 14.0, College Station, Texas).
RESULTS
A total of 59 embolization procedures were performed on 55 patients. The average age was 53 yr, and a majority (64%) of patients were female. The average aneurysm size was 9.4 mm and there were 19 large and 3 giant aneurysms treated. Morphology was saccular (45%), fusiform (29%), or dissecting/pseudoaneurysms (25%). Common presenting symptoms included stroke (16%), retreatment for recurrence after prior rupture (9%), trauma (5%), subarachnoid hemorrhage (SAH; 4%), and mass effect (2%), while 64% were incidental. A minority of aneurysms (20%) were previously treated, most commonly with coiling (9%; Table 1 ). More than half (62%) of posterior circulation aneurysms included in this series arose along the vertebral artery, most commonly at the V4 segment (25%), vertebrobasilar junction (VBJ; 16%), or posterior inferior cerebellar artery (PICA) (15%). There were 7 mid-basilar (13%) aneurysms, 7 basilar apex (13%) aneurysms, 5 posterior cerebral artery (PCA) (9%), and 2 superior cerebellar artery (SCA) (4%) aneurysms (Table 2) .
Procedural success was achieved in 58/59 cases (98%). A single PED was placed in 85% of cases. Adjunctive coiling was performed in 17% of cases. Intraprocedural stent thrombosis was observed and treated with intra-arterial abciximab in 3 cases (5%), after which it resolved without symptoms ( Table 3 ). The unsuccessful case was a 15-mm dissecting mid-basilar aneurysm in which was aborted when the distal device would not sit in the distal basilar artery; at a later date, the case was completed successfully when the PED was placed from P2 back into the basilar artery. This patient developed right-sided hemiparesis on postoperative day 2 at which time magnetic resonance imaging (MRI) showed pontine infarct secondary to perforator occlusion ( procedures, two for retreatment of persistent aneurysm filling that ultimately led to occlusion. The third underwent retreatment because the distal end of the original PED foreshortened into the 21-mm fusiform mid-basilar aneurysm. Four years after successful retreatment, after stopping Plavix with medical advice, the patient had a pontomedullary infarct and ultimately expired (case 6, Figure 1 ). In the entire series, there were 5 major complications (9%), all ischemic strokes. There were zero intracranial hemorrhages or SAH. Patients with major stroke had modified Rankin Scale score (mRS) at last follow-up of 1, 3, 4, 6, and 6. The 3 major complications not described above were: case 5: A sexagenarian with a 14-mm fusiform left V4 aneurysm and intracranial atherosclerosis treated with 4 telescoping PED from the proximal basilar to V3. The patient awoke with right-sided weakness and was found to have scattered diffusion restricted in bilateral PCA territories, presumed embolic. Case 27: A sexagenarian with an 11-mm saccular P1 aneurysm treated with a single PED within the PCA who was noncompliant with Plavix and presented 1 mo postembolization with confusion and sensory loss secondary to stent occlusion and PCA territory infarct. Case 56: A septuagenarian with an irregular 4-mm wide-necked basilar apex aneurysm treated with a single PED from the left PCA to midbasilar artery who presented with left-sided hemiparesis 2 wk postembolization and thalamic and pontine strokes secondary to perforator occlusion.
The minor complication rate was 7%, including minor stroke, TIA, and cranial nerve palsy (Table 5) . No variableincluding aneurysm size, morphology, vessel of origin, and PED location, among others-was predictive of complications on either univariate or multivariate analysis. The average length of stay postembolization was 3.6 d and 72% of patients were discharged home on postembolization day 1 or 2.
Follow-up catheter angiography was performed for 43 patients (78%). Complete occlusion was 68% at 6 mo and 78% at 12 mo. The average follow-up interval was 11.8 mo (±11.8; Table 6 ). Fusiform or dissecting morphology (as compared to saccular; odds ratio [OR] 25.814, P = .004), large or giant aneurysm size (OR = 7.643, P = .043), and SCA or PCA aneurysm (OR 27.889, P = .045) were significant predictors of aneurysm persistence at 6 mo on multivariate logistic regression.
DISCUSSION
In this series of 55 patients undergoing 59 procedures, flow diversion of posterior circulation cerebral aneurysms with the PED showed high rates of aneurysm occlusion and acceptably low complication rates for this difficult to treat and highly morbid class of aneurysms. Complete occlusion was achieved in 78% of patients at 12-mo follow-up, with larger size and nonsaccular morphology predicting persistence. The major complication rate was 8%, which included 3 perforator strokes, 1 stent occlusion secondary to antiplatelet noncompliance, and 1 embolic stroke. This is a large posterior circulation flow diversion series with outcomes that compare favorably to alternative open and endovascular treatment modalities.
Meta-analyses have shown increased risk of ischemic complications and comparable risk of hemorrhagic complications with flow diversion of posterior circulation aneurysms as compared to anterior circulation. 11 Morphology is partly to blame, with a preponderance of large, partially thrombosed nonsaccular aneurysms in the posterior circulation, which are prone to thrombus propagation leading to perforator infarction or stent occlusion. In one of the earliest reports of posterior circulation flow diversion, among 7 patients with large or giant fusiform basilar artery aneurysms treated at the University of Buffalo and reported in 2012, there were 2 who presented with brain stem ischemic symptoms that progressed to death after flow diversion. The strokes were attributed to occlusion of perforators previously maintained through tenuous channels within existing thrombus after coverage by multiple telescoping devices. 12 We observed similar morbidity with flow diversion of dolichoectatic basilar artery aneurysms (2 major and 1 minor complications among 7 patients), and have only treated 1 such aneurysm since 2013. Subsequent studies have shown that perforator infarction rates are lower in smaller aneurysms and when fewer devices are used but that basilar perforators remain vulnerable. In a series of 32 posterior circulation aneurysms with size (9.7 mm) and morphology (63% fusiform or dissecting) closely mirroring the present series, Phillips et al 13 reported 5 major complications, including 3 perforator infarctions. All 3 perforator strokes occurred among the 21 patients treated with a single PED partially or entirely within the basilar artery. The comparatively good safety outcomes in this series may be due to a preponderance of aneurysms isolated to the vertebral artery. Our major complication rate (8%) was lower than the series by Phillips et al, 13 but as with that series all major strokes occurred in patients treated with a PED partially in the basilar artery or PCA, and such patients represented a smaller share of this series (56%). General comparisons between posterior circulation flow diversion series are to be avoided, recognizing that the outcomes of each series reflect their proportionate composition of heterogeneous groups of aneurysms.
Munich et al 14 sought to avoid perforator infarctions in their series of 12 fusiform vertebral artery aneurysms treated with flow diversion by using a higher porosity Enterprise stent (Codman Neuro, DePuy Synthes, Johnson & Johnson, New Brunswick, New Jersey) beyond the anterior inferior cerebellar artery in the 1 case where the construct extended this far. While the authors observed no perforator infarctions, the overall major complication rate was 25%, and the patient treated with Enterprise stent (Johnson & Johnson) had an endoleak and persistent aneurysm filling at last follow-up.
14 Vertebral artery perforators are also potentially vulnerable, as an updated report from the University of Buffalo demonstrates. Natarajan et al 15 used an average of 1.7 devices to treat 12 posterior circulation aneurysms with average size of 13 mm and encountered 1 major complication, a pontomedullary infarct attributed to occlusion of a distal vertebral perforating artery. In this series, 3 of the 5 major complications observed were attributed to perforator infarction. One of these (case 6, Figure 1 ) was a quinquagenarian whose 21-mm fusiform VBJ aneurysm was initially treated with 4 mm ×35 mm PED from mid-basilar to V4 and subsequently treated with a 5 mm ×20 mm device placed when the first device foreshortened proximally and did not cover the aneurysm neck. The patient did well initially but experienced brain stem perforator strokes shortly after stopping Plavix 4 yr after treatment. The other 2 perforator infarctions were patients with mid-basilar (case 33) and basilar apex (case 56) aneurysms in whom the pipeline construct covered the basilar apex. While these distal basilar perforating arteries do appear most vulnerable, 12 of the 14 patients in this series in whom the pipeline device covered the basilar apex did not experience any ischemic issues or other morbidity. PED coverage of the basilar apex was not a significant predictor of complication on univariate or multivariate analysis.
Device sizing is a critical decision that can reduce the risk of perforator infarction. In the distal basilar artery, we titrate the degree of metal coverage by using devices with relatively short length and oversized diameter, as in the case of a quaternarian with a recurrent, previously ruptured and coiled basilar apex aneurysm in whom an oversized 3.75 × 14-mm device was placed from the right PCA extending into the distal basilar artery (Figure 2 ). In these cases, the oversized PED reduces flow diversion in the perforator-rich PCA and distal basilar artery but opens more widely in the basilar apex to maximize apposition and promote endothelialization at the aneurysm neck.
Jailed vessel occlusion is a second mechanism for stroke that has given interventionists pause about using Pipeline in the posterior circulation. Saatci et al 16 treated 251 aneurysms with PED, including 14 posterior circulation aneurysms, with an overall permanent morbidity rate of 1%. The 1 mortality in that series was attributed to occlusion of a jailed right PCA in a patient who had PED placed from left PCA into the distal basilar artery to treat a right SCA aneurysm. The authors did not comment on the presence of a posterior communicating artery supplying the jailed PCA. 16 Chalouhi et al 17 reported a series of 7 posterior circulation aneurysms treated with PED and followed for 5.5 mo in which no major complications were observed. The authors credited their excellent outcomes in part to a refusal to treat bifurcation aneurysms out of concern for stroke related to occlusion of a jailed vessel. We believe this risk is exaggerated. In our experience, the status of the posterior communicating arteries is critical to deciding whether and how to flow divert a distal posterior circulation aneurysm. A jailed PCA that is robustly collateralized by the posterior communicating artery will progressively occlude at its origin from the basilar apex without the patient experiencing symptoms, as in the illustrative case of a quadragenarian with previously ruptured, recurrent basilar apex aneurysm treated with PED from the right PCA into the distal basilar artery (Figure 3) . Stent occlusion is a third mechanism for ischemic stroke that has been observed with flow diversion of posterior circulation aneurysms, often coinciding with changes in antiplatelet therapy. The second patient treated with Pipeline by Fiorella et al 18 had 3 telescoping devices placed to treat a 14-mm V4 aneurysm. Digital subtraction angiography at 12 mo demonstrated complete occlusion of the aneurysm with a patent parent vessel; Plavix was discontinued at 18 mo and the patient presented with vessel occlusion at 23 mo postembolization that progressed to thrombosis of the entire posterior circulation leading to death. 18 Klisch et al 19 observed this phenomenon in 2 patients with large fusiform aneurysms treated with telescoping PED in whom 12-mo DSA showed persistent but reduced aneurysm filling; Plavix was stopped and both presented with symptomatic stent occlusion within 14 d. 19 Likewise, Meckel et al 20 reported a case of a giant fusiform VBJ aneurysm treated with 9 overlapping PEDs. Eleven-month postprocedural angiogram demonstrated minimal residual aneurysm filling and Plavix was stopped; the patient presented with stent thrombosis 2 wk later leading to his demise. 20 These experiences as well as our own observation of perforator strokes shortly after stopping Plavix in a patient treated 4 yr previously (case 6) suggest it may never be safe to stop DAT in posterior circulation flow diversion cases.
Several reports also exist of early antiplatelet noncompliance leading to stent occlusion in treated posterior circulation aneurysms. [21] [22] [23] In our series, we observed stent thrombosis with PCA territory stroke 2 mo after treatment in a patient with a P1 saccular aneurysm who self-discontinued Plavix (case 27).
As with all cases of intracranial stent placement, flow diverter or other, medical noncompliance with antiplatelet regimens can result in stroke. Posterior circulation flow diversion requires strict attention to antiplatelet therapy; but rather than titration to P2Y12 levels, we have learned to prolong the duration of therapy and broaden the repertoire of agents used. We are skeptical of P2Y12 levels, given our observation of low rates of ischemic complications in Plavix hypo-responders undergoing anterior circulation flow diversion. 24 Nevertheless, we have measured P2Y12 levels for patients undergoing posterior circulation flow diversion since 2014. Among the 32 patients with P2Y12 Reaction Units levels, 8 were Clopidogrel "hypo-responders" with levels >200. The 1 complication that occurred in this group was in the patient who prematurely self-discontinued Plavix who had a marginally therapeutic pre-embolization P2Y12 of 215 (case 27). Based on literature observation and our experiences with delayed strokes, we now maintain patients undergoing posterior circulation flow diversion on DAT for life. For basilar apex-region aneurysms, we have transitioned to using Prasugrel rather than Clopidogrel primarily. We also keep all patients undergoing posterior circulation flow diversion systemically heparinized for 24 h postembolization. This moderates the rate at which aneurysms thrombose and guards against acute propagation into a perforator, parent vessel, or covered branch vessel. The risk of anticoagulation-associated hemorrhagic complications appears to be lower than in anterior circulation flow diversion and the dependent parenchyma less eloquent. 25 Overall occlusion outcomes observed in this series were comparable to our experience with anterior circulation aneurysms. Complete occlusion was 68% at 6 mo and 78% at 12 mo as compared with 72% and 78% at similar intervals in patients with anterior circulation aneurysms treated with Pipeline at our institution (Bender et al in-press ). 26 As others have observed, 15, 22 fusiform and dissecting aneurysms of the basilar artery can be cured with single modality flow diversion particularly when treated while the aneurysm is relatively small (Figure 4 ). Occlusion outcomes with flow diversion of large dolichoectatic vertebrobasilar aneurysms (0% complete occlusion among 7 treated patients) were poor. Single-modality flow diversion has reduced efficacy for aneurysms located at a branch vessel supplying a terminal circulation, 27 as in the case of SCA aneurysms for which we have combined coiling and flow diversion to achieve cure without the risk of recurrence associated with stent-coiling ( Figure 5 ).
Compared to anterior circulation flow diversion, there was a higher percentage of large aneurysms and nonsaccular aneurysms in this series, both of which were predictors of persistence on multivariate analysis. Treating a fusiform or dissecting aneurysm in the posterior circulation is different than the anterior circulation. We use a single device whenever possible and use adjunctive coiling to expedite occlusion rather than telescoping multiple devices as one might in the anterior circulation to increase metal surface coverage while also risking perforator infarction. Spanning a fusiform segment with a single PED may require choosing longer and large diameter devices than are typically used in the anterior circulation. We have seen reliable opening and improved apposition of these larger devices in the straighter anatomy of the posterior circulation. Overall occlusion outcomes in this series may have been bolstered by higher rates of adjunctive coiling (17% vs 5% in our anterior circulation experience). Although adjunctive coiling is known to be a predictor of occlusion from our experience with anterior circulation flow diversion (Bender et al in-press) 26 , it was not a significant predictor of occlusion in this series, likely due to the smaller number of patients.
Occlusion outcomes observed in this series are comparable to the literature on PED for posterior circulation aneurysms. Among the largest experiences, occlusion rates were lower (57% at last follow-up) in Bhogal's series of 58 nonsaccular posterior circulation aneurysms treated with flow diverters. 22 Phillips et al 13 treated 32 posterior circulation aneurysms and observed complete occlusion rates of 85% at 6 mo and 96% at 12 mo but performed adjunctive coiling in 35% of cases. The meta-analysis by Wang et al 28 including 225 posterior circulation aneurysms reported 84% occlusion at 6 mo.
Because of the need for DAT, flow diversion is reserved for exceptional cases of acute SAH, of which there were 2 in this series: a 6-mm dissecting V4 aneurysm and a blister VBJ aneurysm with a 2-mm height, 5-mm neck, and multiple secondary dilations. Given the wide-necked nature of both aneurysms, a stent was required to support any coils and a flow diverter was selected to maximize the chances of occlusion given the limited coil density allowed by the shallow depth of each aneurysm. The timing of intervention and protocol for initiating DAT have been discussed elsewhere in series of flow diversion for SAH; 29 the need for cerebrospinal fluid diversion must be accounted for in ruptured posterior circulation aneurysms given their propensity to present with intraventricular hemorrhage. Both SAH patients in this series ultimately made a full recovery (mRS 0) and had complete aneurysm occlusion on follow-up DSA.
The heterogeneity of our cohort prevents direct comparison to alternative treatment modalities, but what is clear is that throughout the posterior circulation each modality carries significant risks and tradeoffs to achieve aneurysm obliteration. Petr et al 30 recently published a meta-analysis of 920 PICA aneurysms, of which 136 were treated electively. Surgery achieved complete occlusion for 93% of aneurysms with a recurrence rate of 15% and long-term morbidity of 8% and mortality of 7%. Endovascular coiling achieved complete occlusion for 76% with a recurrence rate of 12%, morbidity of 5%, and mortality of 4%. 30 None of the major complications encountered in the present series occurred in the 8 PICA aneurysms or 15 vertebral artery aneurysms proximal to the basilar that were treated. Surgical treatment of fusiform aneurysms of the VBJ and proximal basilar artery requires deliberate occlusion for flow reversal or bypass. In Drake's hands, good outcomes were achieved by 73% of patients undergoing basilar or vertebral artery occlusion. 4 More distally in the posterior circulation, surgical treatment of basilar apex aneurysms has substantial morbidity even at the highest volume centers. Lawton reported a series of 56 patients with an average size of 11 mm and in which 55% had ruptured aneurysms, with outcomes that included 13% mortality and 5% permanent morbidity. 5 Stent-coiling has lower complication rates but also comparatively inferior occlusion outcomes. Fargen et al 6 reported a multi-institution series of 45 patients with bifurcation aneurysms treated with Y-stent coiling, of which 87% were basilar apex aneurysms. In this primarily unruptured cohort, mRS 0 to 2 was achieved by 93% of patients at last follow-up; however, occlusion was complete in just 60%. 6 
Limitations
The limitations of this series include those shared with any retrospective observational clinical study. More specifically, posterior circulation aneurysms are an admittedly heterogeneous population, including saccular aneurysms treated to eliminate the risk of rupture and fusiform aneurysms treated to alleviate symptoms of mass effect and mitigate stroke risk. In particular, dolichoectatic vertebrobasilar aneurysms appear to be a distinct subset with a poor natural history and poor outcomes after flow diversion. We included these cases in this series to fully disclose our experience posterior circulation flow diversion and because these aneurysms exist on a continuum with smaller fusiform aneurysms, which can be treated successfully with flow diversion. Follow-up was limited to 12 mo on average; long-term follow-up would likely show higher occlusion and is particularly important in this population that appears to be at greater risk of presenting with delayed complications. We sought to strike an appropriate balance between relevant follow-up that would capture major complications and early aneurysm occlusion outcomes and timely publication given the limited literature on posterior circulation flow diversion.
CONCLUSION
As compared with their anterior circulation counterparts, posterior circulation cerebral aneurysms are more likely to cause symptoms associated with mass effect or strokes and are at higher risk of rupture. Existing endovascular and open surgical treatments are limited by efficacy and morbidity. This is a large series of 59 PED flow diversion procedures demonstrating PED is safe and effective and represents a valuable addition to the neurosurgical armamentarium for treating posterior circulation cerebral aneurysms.
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